Your browser doesn't support javascript.
loading
Prevalence of Heart Failure Stages in a Universal Health Care System: The Military Health System Experience.
Roger, Véronique L; Banaag, Amanda; Korona-Bailey, Jessica; Wiley, Tiffany M Powell; Turner, Clesson E; Haigney, Mark C; Koehlmoos, Tracey Perez.
Afiliación
  • Roger VL; Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Md. Electronic address: veronique.roger@nih.gov.
  • Banaag A; Uniformed Services University of the Health Science, Bethesda, Md; Henry M. Jackson Foundation for the Advancement of Military Medicine Inc, Bethesda, Md.
  • Korona-Bailey J; Uniformed Services University of the Health Science, Bethesda, Md; Henry M. Jackson Foundation for the Advancement of Military Medicine Inc, Bethesda, Md.
  • Wiley TMP; Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Md; National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, Md.
  • Turner CE; National Human Genome Research Institute, National Institutes of Health, Bethesda, Md.
  • Haigney MC; Military Cardiovascular Outcomes Research, Cardiology Division, Uniformed Services University, Bethesda Md.
  • Koehlmoos TP; Uniformed Services University of the Health Science, Bethesda, Md.
Am J Med ; 136(11): 1079-1086.e1, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37481019
ABSTRACT

BACKGROUND:

Morbidity and mortality related to heart failure are increasing and disparities are widening. These alarming trends, often confounded by access to care, are poorly understood. This study evaluates the prevalence of all stages of heart failure by race and socioeconomic status in an environment with no access barrier to care.

METHODS:

We conducted a cross-sectional observational study of adult beneficiaries aged 18 to 64 years of the Military Health System (MHS), a model for universal health care for fiscal years 2018-2019. We calculated prevalence of preclinical (stages A/B) or clinical (stages C/D) heart failure stages as defined by professional guidelines. Results were analyzed by age, race, and socioeconomic status (using military rank as a proxy).

RESULTS:

Among 5,440,761 MHS beneficiaries aged 18 to 64 years, prevalence of preclinical and clinical heart failure was 18.1% and 2.5%, respectively. Persons with preclinical heart failure were middle aged, with similar proportions of men and women, while those with heart failure were older, mainly men. After multivariable adjustment, male sex (1.35 odds ratio [OR] [preclinical]; 1.95 OR [clinical]), Black race (1.64 OR [preclinical]; 1.88 OR [clinical]) and lower socioeconomic status were significantly associated with large increases in the prevalence of all stages of heart failure.

CONCLUSION:

All stages of heart failure are highly prevalent among MHS beneficiaries of working age and, in an environment with no access barrier to care, there are striking disparities by race and socioeconomic status. The high prevalence of preclinical heart failure, particularly notable among Black beneficiaries, delineates a critical time window for prevention.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Am J Med Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Am J Med Año: 2023 Tipo del documento: Article